CDx Inquiries

AccuGenomics’ highly versatile SNAQ™-SEQ spike-in control technology is available for co-development to support targeted Next Generation Sequencing, RNA expression, Whole Exome Sequencing, and more.  Designing assays with a spike-in control strategy from the outset will yield better performing assays with faster market adoption and a more satisfied customer base.  SNAQ™-SEQ is a cost-effective tool to improve your development and commercial rollout.  AccuGenomics is happy to provide consultatory support services on how to integrate SNAQ™-SEQ spike in control technology for your targeted NGS assay.

Stay Informed

Get the latest updates and news


© 2020 AccuGenomics, Inc. All Rights Reserved.